Perspective: Hexosamines and Nutrient Sensing
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The prevalence of obesity and type 2 diabetes mellitus has increased concomitantly with the introduction of nutrients with high caloric density and more sedentary lifestyle in western societies. The tight association between insulin resistance and weight gain is likely to play a pivotal role in this “epidemic.” During the last decade, the relationship between nutrient availability and insulin action has been object of intense debate and novel hypotheses have emerged (1–10). A common theme is that the availability of nutrients per se may modulate insulin action toward nutrient storage and disposal within the framework of a homeostatic system designed to regulate energy balance at the cellular and whole body level. Consistent with this view, insulin resistance is acquired as an“ adaptation” to nutrient excess. This hypothesis rests on the existence of biochemical pathways capable of ‘sensing’ the availability of nutrients and activating the appropriate metabolic/endocrine responses. The current brief perspective is centered on the pleiotropic functions of one of these nutrient sensing pathways, the hexosamine biosynthesis pathway. It has long been recognized that isolated cells have a remarkable ability to adapt to the nutritional environment. For example, cells cultured in the presence of very low glucose tend to up-regulate their basal transport system via increased expression of GLUT1. Similarly, the relative oxidation of lipids and carbohydrates is finely regulated by biochemical mechanisms pacing the rate of entry of long-chain CoAs into the mitochondria (the “malonyl CoA fuel sensing” system) (6, 9, 11, 12). Marshall et al. (4) first proposed that the metabolism of glucose by the hexosamine pathway generates a signal of“ cellular satiety” (Fig. 1). In insulin target tissues, this signal leads to the desensitization of the glucose transport system to subsequent stimulation by insulin (4). In fact, prolonged incubation of cultured adipocytes in the presence of high glucose and insulin resulted in a marked decrease in insulin’s stimulation of glucose uptake. This effect of glucose was mimicked by incubation with glucosamine and was prevented by antagonism of the enzyme glutamine:fructose-6-P amidotransferase (GFAT), which catalyzes the first step in the metabolism of glucosyl units in the hexosamine pathway (4, 13). These observations supported the notion of nutrient sensing in isolated adipose cells. In the present issue of the journal, Crook et al. (14) report an interesting observation, which suggest a novel role of the hexosamine pathway in metabolic partitioning of substrates. Overexpression of GFAT in cultured fibroblasts resulted in decreased activity of glycogen phosphorylase (14) and therefore increased accumulation of glycogen (14–16). The latter can be interpreted as an attempt to maintain the hexose-phosphate pool at stable levels when a signal of “cellular satiety” is generated. Schematic representation of the hexosamine biosynthesis pathway. Following its entry into muscle or adipose cells via the glucose transport system and its rapid phosphorylation to glucose-6-phosphate (Glc-6-P), glucose is primarily utilized by the pathways of glycogen synthesis and glycolysis. The hexosamine pathway receives approximately 1–3% of incoming glucose via the conversion of frustose-6-phosphate (Fru-6-P) to glucosamine-6-phosphate by the rate-limiting enzyme glutamine: fructose-6-phosphate amidotransferase (GFAT). The principle endproduct of this pathway, uridinediphosphoglucose-n-acetylglucosamine (UDP-GlcNAc) serves as substrate for virtually all glycosilation pathways. In adipose cells and in skeletal muscle, following the transport and phosphorylation of glucose to glucose-6-phosphate (Glc-6-P), the latter is primarily used in two major pathways, i.e. glycogen synthesis and glycolysis (4, 17). However, approximately 1–3% of the incoming glucose that is converted to fructose-6-phosphate (Fru-6-P) enters the hexosamine biosynthetic pathway (Fig. 1), whose major end product, UDP-N-acetyl-glucosamine (UDP-GlcNAc) serves as substrate for multiple glycosylation reactions. Several recent studies have demonstrated that increased flux of Fru-6-P into the hexosamine biosynthesis pathway antagonizes the ability of insulin to stimulate glucose uptake in vivo and in isolated cell systems (4, 5, 15, 18–26). The latter represents a likely mechanism by which chronic hyperglycemia results in defective stimulation of glucose transport by insulin (8). In the presence of increased availability of FFA, the increased concentration of acetyl-CoA, derived in the mitochondria from the oxidation of FFA, decreases the rate of pyruvate oxidation via inhibition of pyruvate dehydrogenase (PDH) (7). Furthermore, the entry of fructose-6-P in the glycolytic pathway is also limited by the inhibition of phosphofructokinase (PFK) (Fig. 1). This in turn is expected to increase the availability of fructose-6-P for the formation of glucosamin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660
Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice
Coleman, D. L. (1978) · Diabetologia · doi:10.1007/bf00429772 · Cited by 1,307
Schwartz, M. W., Baskin, D. G., Bukowski, T. R., Kuijper, J. L., Foster, D., Lasser, G., Prunkard, D. E., Porte, D., Woods, S. C., Seeley, R. J., et al. (1996) · Diabetes · doi:10.2337/diab.45.4.531 · Cited by 904
A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.
McGarry, J. D., Mannaerts, G. P., & Foster, D. W. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108764 · Cited by 736 · cited 1×
“Similarly, the relative oxidation of lipids and carbohydrates is finely regulated by biochemical mechanisms pacing the rate of entry of long-chain CoAs into the mitochondria (the “malonyl CoA fuel sensing” system) (6, 9, 11, 12).”
Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro
Kolaczynski, J. W., Nyce, M. R., Considine, R. V., Boden, G., Nolan, J. J., Henry, R., Mudaliar, S. R., Olefsky, J., & Caro, J. F. (1996) · Diabetes · doi:10.2337/diab.45.5.699 · Cited by 700
Intracerebroventricular Leptin Regulates Hepatic but Not Peripheral Glucose Fluxes
Liu, L., Karkanias, G. B., Morales, J. C., Hawkins, M., Barzilai, N., Wang, J., & Rossetti, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31160 · Cited by 222
Self-citation
Cited by
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Insulin Resistance: From Mechanisms to Therapeutic Strategies
Lee, S.-H., Park, S.-Y., & Choi, C. S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0280 · Cited by 1,092
Leptin: a review of its peripheral actions and interactions
Margetic, S., Gazzola, C., Pegg, G., & Hill, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802142 · Cited by 1,005
A chemical approach for identifying O -GlcNAc-modified proteins in cells
Vocadlo, D. J., Hang, H. C., Kim, E.-J., Hanover, J. A., & Bertozzi, C. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1632821100 · Cited by 538
Metadata
- Authors
- Rossetti, L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2000-06-01
- Volume
- 141
- Issue
- 6
- Pages
- 1922-1925
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2089266364
- Cited by
- 139
- References
- 9
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perspective: Hexosamines and Nutrient Sensing. https://app.cochat.ai/papers/10.1210/en.141.6.1922
- The paper
- Rossetti, L. (2000). Perspective: Hexosamines and Nutrient Sensing. Endocrinology. https://doi.org/10.1210/en.141.6.1922
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.